FacultyFaculty/Author Profile
Catherine A. Sazdanoff

Catherine A. Sazdanoff

Strata Oncology, Inc.
Chief Business Officer
Lake Forest, IL, USA


Catherine is an experienced global healthcare consultant and board member. She is Business Advisor at Strata Oncology, Inc., a precision medicine company, where she provides strategic, business development and marketing advisory services and also manages the legal and intellecutal property functions. She is an independent director and Audit Committee member of the Board of Directors of Meridian Bioscience, Inc. (NASDAQ: VIVO), a diagnostics and life sciences company, and serves on the Advisory Board of Neurocern, Inc., a dementia management systems startup. Catherine is involved in several volunteer organizations, including Chicago Innovation Mentors @ MATTER, and the Life Sciences Advisory Council of Springboard Enterprises, which supports female entrepreneurs.

Catherine previously held senior roles at Takeda Pharmaceuticals and Abbott Laboratories in corporate and business development, legal, compliance, and global finance functions. She led strategy development and deal execution in transformative M&A (e.g., Takeda $13B acquisition of Nycomed S.A. for geographic expansion; Takeda $9B acquisition of Millennium Pharmaceuticals for enhanced oncology revenue and capabilities; Abbott $7B acquisition of Knoll Laboratories, expanding global presence and assets including mega- blockbuster Humira). She also built and led global business development teams for R&D and commercial collaborations, across multiple therapeutic areas such as CNS, cardiovascular, metabolic, GI, renal, respiratory and immunology, continuing hands-on responsibility in structuring, diligence, negotiation and governance of critical partnerships. Catherine also led global restructuring and organization design (e.g., WW cross-functional recurring savings of >$500 MM for Takeda; global organization design, build, and management as senior member of Abbott Office of Ethics & Compliance), conducted enterprise risk assessments and internal investigations, and litigated successfully in antitrust, IP, employment, contract, mass tort, shareholder and government actions.

In addition to her corporate work, Catherine previously provided advisory and consulting services on strategy development, corporate development, transactions and other aspects of building and growing a business. Her clients included a specialty pharmaceutical company in women’s health, a mobile health company in pharmaceutical clinical research, and a startup company developing novel pain management therapy.

Catherine A. Sazdanoff is associated with the following items:
CHB Chapters  CHB Chapters Key Considerations in License Agreements Specific to the Life Sciences Industry - Advanced Licensing Agreements 2018, Tuesday, January 23, 2018
Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • YouTube
  • RSS

All Contents Copyright © 1996-2018 Practising Law Institute. Continuing Legal Education since 1933.

© 2018 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.